Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma
Open Access
- 12 December 2011
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 208 (13), 2657-2673
- https://doi.org/10.1084/jem.20111102
Abstract
In glioblastoma multiforme, an EGFR–GBP1–matrix metalloproteinase-1 cascade drives tumor invasion but does not alter tumor proliferation, survival, or angiogenesis.Keywords
This publication has 53 references indexed in Scilit:
- TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle RegenerationCell Stem Cell, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma PatientsCancer Research, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileMolecular Cancer, 2008
- EFA6A Enhances Glioma Cell Invasion through ADP Ribosylation Factor 6/Extracellular Signal–Regulated Kinase SignalingCancer Research, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expressionThe EMBO Journal, 2003
- The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokinesThe EMBO Journal, 2001
- Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cellsEuropean Journal of Cancer, 1996